SG11202009914SA - Aav-compatible laminin-linker polymerization proteins - Google Patents

Aav-compatible laminin-linker polymerization proteins

Info

Publication number
SG11202009914SA
SG11202009914SA SG11202009914SA SG11202009914SA SG11202009914SA SG 11202009914S A SG11202009914S A SG 11202009914SA SG 11202009914S A SG11202009914S A SG 11202009914SA SG 11202009914S A SG11202009914S A SG 11202009914SA SG 11202009914S A SG11202009914S A SG 11202009914SA
Authority
SG
Singapore
Prior art keywords
aav
laminin
compatible
linker
proteins
Prior art date
Application number
SG11202009914SA
Other languages
English (en)
Inventor
Peter Yurchenco
Karen Mckee
Original Assignee
Rutgers The State University Of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers The State University Of New Jersey filed Critical Rutgers The State University Of New Jersey
Publication of SG11202009914SA publication Critical patent/SG11202009914SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A01K2217/077—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out heterozygous knock out animals displaying phenotype
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202009914SA 2018-05-08 2019-05-08 Aav-compatible laminin-linker polymerization proteins SG11202009914SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862668664P 2018-05-08 2018-05-08
PCT/US2019/031369 WO2019217582A1 (fr) 2018-05-08 2019-05-08 Protéines de polymérisation de lieur-laminine compatibles avec aav

Publications (1)

Publication Number Publication Date
SG11202009914SA true SG11202009914SA (en) 2020-11-27

Family

ID=68468357

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009914SA SG11202009914SA (en) 2018-05-08 2019-05-08 Aav-compatible laminin-linker polymerization proteins

Country Status (10)

Country Link
US (1) US20210207168A1 (fr)
EP (1) EP3790394A4 (fr)
JP (1) JP7253274B2 (fr)
KR (1) KR20210006352A (fr)
CN (1) CN112154209A (fr)
AU (1) AU2019265663A1 (fr)
CA (1) CA3098871A1 (fr)
IL (1) IL278393B2 (fr)
SG (1) SG11202009914SA (fr)
WO (1) WO2019217582A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114555814A (zh) * 2019-09-13 2022-05-27 罗特格斯新泽西州立大学 Aav相容的层粘连蛋白-连接子聚合蛋白
EP3842452A1 (fr) * 2019-12-26 2021-06-30 Universitat Autònoma de Barcelona Protéines d'échafaudage et nanoconjugués thérapeutiques à base de nidogène

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5478745A (en) 1992-12-04 1995-12-26 University Of Pittsburgh Recombinant viral vector system
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
US6001650A (en) 1995-08-03 1999-12-14 Avigen, Inc. High-efficiency wild-type-free AAV helper functions
WO1998010088A1 (fr) 1996-09-06 1998-03-12 Trustees Of The University Of Pennsylvania Procede inductible de production de virus adeno-associes recombines au moyen de la polymerase t7
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
ATE331785T1 (de) * 2000-03-29 2006-07-15 Beth Israel Hospital Anti-angiogenic properties of matin and of fragments or variants thereof
NZ532635A (en) 2001-11-13 2007-05-31 Univ Pennsylvania A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
ES2648241T3 (es) 2003-09-30 2017-12-29 The Trustees Of The University Of Pennsylvania Clados de virus adenoasociados (AAV), secuencias, vectores que contienen el mismo, y usos de los mismos
JPWO2006043354A1 (ja) * 2004-10-20 2008-05-22 独立行政法人放射線医学総合研究所 組込型の低線量放射線誘導性ベクター
ES2525067T3 (es) 2005-04-07 2014-12-17 The Trustees Of The University Of Pennsylvania Método de incremento de la función de un vector de AAV
WO2009137006A2 (fr) 2008-04-30 2009-11-12 The University Of North Carolina At Chapel Hill Évolution dirigée et méthode d'adhérence sur plastique in vivo de vecteurs viraux
EP2500434A1 (fr) 2011-03-12 2012-09-19 Association Institut de Myologie Vecteurs AAV sans capside, compositions et procédés pour la production des vecteurs et la thérapie génique
TWI775096B (zh) * 2012-05-15 2022-08-21 澳大利亞商艾佛蘭屈澳洲私營有限公司 使用腺相關病毒(aav)sflt-1治療老年性黃斑部退化(amd)
US9943574B2 (en) * 2012-06-27 2018-04-17 Arthrogen B.V. Combination for treating an inflammatory disorder
ES2862526T3 (es) 2014-01-21 2021-10-07 Univ Brussel Vrije Elementos reguladores de ácido nucleico específicos de músculo y métodos y uso de los mismos
CA2978917A1 (fr) * 2015-03-10 2016-09-15 The Trustees Of Columbia University In The City Of New York Constructions de vecteur viral adeno-associe glut1 de recombinaison et procedes associes permettant de restaurer l'expression de glut1

Also Published As

Publication number Publication date
KR20210006352A (ko) 2021-01-18
CN112154209A (zh) 2020-12-29
JP2021522791A (ja) 2021-09-02
AU2019265663A1 (en) 2020-10-29
JP7253274B2 (ja) 2023-04-06
IL278393B2 (en) 2023-11-01
EP3790394A4 (fr) 2022-07-27
US20210207168A1 (en) 2021-07-08
IL278393A (fr) 2020-12-31
IL278393B1 (en) 2023-07-01
CA3098871A1 (fr) 2019-11-14
WO2019217582A1 (fr) 2019-11-14
EP3790394A1 (fr) 2021-03-17

Similar Documents

Publication Publication Date Title
IL271340A (en) Scaffolding proteins
IL275298B1 (en) Mitochondria-targeted peptides
DK3737402T3 (en) Modificeret protein
CA184989S (en) Uroflowmeter
GB201608197D0 (en) Novel proteins
SG11202009914SA (en) Aav-compatible laminin-linker polymerization proteins
GB201820983D0 (en) Virus
GB201805799D0 (en) b
IL284006A (en) Mitochondria-targeted peptides
GB2558968B (en) G Proteins
GB201700557D0 (en) Novel peptides
GB201807853D0 (en) Polymers
GB201810052D0 (en) Polypeptide
IL291310A (en) aav-compatible proteins for polymerization bind to laminin
GB201909710D0 (en) Proteins
GB201807863D0 (en) Peptides
GB201913320D0 (en) Novel proteins
GB201806181D0 (en) Peptides
GB201805801D0 (en) Peptides
GB201805807D0 (en) Peptides
GB201805809D0 (en) Peptides
GB201904756D0 (en) Novel proteins
GB201815523D0 (en) Polymers
GB201901706D0 (en) b
GB201814440D0 (en) Peptide